The arrhythmogenic cardiomyopathy-specific coding and non-coding transcriptome in human cardiac stromal cells.
Johannes Rainer1, Viviana Meraviglia2, Hagen Blankenburg3
1Institute for Biomedicine, Eurac Research, Affiliated Institute of the University of Lübeck, Viale Druso 1, 39100, Bolzano, Italy. johannes.rainer@eurac.edu.
Researchers identified specific gene and microRNA (miRNA) expression profiles in cardiac stromal cells (CStCs) from arrhythmogenic cardiomyopathy (ACM) patients. These findings highlight potential roles for cell adhesion and specific miRNAs in ACM pathogenesis.
Area of Science:
- Cardiovascular Genetics
- Molecular Cardiology
- Cell Biology
Background:
- Arrhythmogenic cardiomyopathy (ACM) is a genetic disorder affecting heart muscle.
- Pathogenesis involves abnormal cell adhesion, cardiomyocyte death, and fibrosis.
- Cardiac stromal cells (CStCs) are newly recognized contributors to ACM.
Purpose of the Study:
- To identify unique gene and microRNA (miRNA) expression profiles in CStCs from ACM patients.
- To understand the role of CStCs in the molecular mechanisms of ACM.
Main Methods:
- Human CStCs were isolated from endomyocardial biopsies of ACM patients and healthy controls.
- miRNA expression profiling was performed using TaqMan Low Density Arrays.
- Gene expression quantification utilized high-throughput sequencing.
Main Results:
- Identified 3 significantly differentially expressed miRNAs and 272 genes in ACM CStCs.
- Differentially expressed genes and miRNA targets are enriched in cell adhesion pathways.
- Network analyses revealed clusters related to cell adhesion, extracellular matrix, lipid transport, and ephrin signaling.
Conclusions:
- First characterization of the coding and non-coding transcriptome of ACM CStCs.
- Evidence suggests a role for miRNAs, particularly miR-29b-3p, in ACM pathogenesis.
- Findings provide insights into CStC contribution to ACM disease mechanisms.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Nursing Code of Ethics
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy


